Asthma maintenance and reliever therapy
نویسندگان
چکیده
منابع مشابه
Single maintenance and reliever therapy (SMART) of asthma.
Around 5.2 million people in the UK are estimated to have asthma.1 Mortality and hospitalisation rates associated with the condition fell significantly in the last 20 years of the 20th century, but have not fallen further since then.2 In 2006, there were over 1,000 asthma deaths and around 78,000 hospital admissions due to asthma in the UK.2 One pharmacological strategy that has been developed ...
متن کامل( SMART ) of asthma Single maintenance and reliever therapy
We write to raise some of a number of serious concerns about the recent paper ‘Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal’. We believe that it is written in a misleading fashion and contains important errors of fact, presentation and inference. Tabulated data for symptoms, reliever use and exacerbations are presented only for patients randomly assigned to SM...
متن کاملSingle maintenance and reliever therapy.
Single maintenance and reliever therapy The paper by Chapman et al reviewing single maintenance and reliever therapy (SMART) in asthma is important in highlighting some of the inadequacies of existing research evaluating this treatment method. The authors also claim that SMART fails to achieve adequate asthma control as measured by GINA criteria and provide a table detailing seven studies and a...
متن کاملUpdated Medication Costs From A Real-Life Cost-Effectiveness Evaluation Of Budesonide/Formoterol Maintenance And Reliever Therapy In Asthma Maintenance And Reliever Therapy In Asthma.
per patient and year compared to SEK 4 710.9 in 2006 per patient and year. The budesonide/formoterol MART arm was also less costly compared to the FDC arm (SEK 4 163.2 per patient and year) and to the FAC arm (SEK 7 498.5 per patient and year) (Table 2). Similar results were found in Denmark where medication costs for the budesonide/formoterol MART arm (DuoResp® Spiromax®) were less in 2015 DKK...
متن کاملBudesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study.
BACKGROUND This non-interventional real-life study (NCT00884689) compared budesonide/formoterol (Symbicort®) maintenance and reliever therapy (SMART™) with a free combination of inhaled corticosteroid (ICS) + long-acting β2-agonist (LABA) (in separate inhalers) and as-needed short-acting β2-agonist (SABA) in adult asthma patients with an exacerbation in the past 24 months. METHODS Asthma pati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Allergy, Asthma & Immunology
سال: 2020
ISSN: 1081-1206
DOI: 10.1016/j.anai.2020.04.009